Clinical practice guidelines for the diagnosis and management of Duchenne muscular dystrophy: a scoping review.

{"article_title":"Clinical practice guidelines for the diagnosis and management of Duchenne muscular dystrophy: a scoping review.","author":"Malaga M, Rodriguez-Calienes A, Chavez-Ecos FA, Huerta-Rosario A, Alvarado-Gamarra G, Cabanillas-Lazo M, Moran-Ballon P, Velasquez-Rimachi V, Martinez-Esteban P, Alva-Diaz C","journal_title":"Frontiers in neurology","issn":"1664-2295","isbn":"","publication_date":"2024 Jan 05","volume":"14","issue":"","first_page":"1260610","page_count":"","accession_number":"38249725","doi":"10.3389\/fneur.2023.1260610","publisher":"Frontiers Research Foundation","doctype":"Journal Article","subjects":"","interest_area":["Pediatric Medicine"," Neurology"],"abstract":"Introduction: Our objective was to identify recent CPGs for the diagnosis and management of DMD and summarize their characteristics and reliability. Methods: We conducted a scoping review of CPGs using MEDLINE, the Turning Research Into Practice (TRIP) database, Google Scholar, guidelines created by organizations, and other repositories to identify CPGs published in the last 5 years. Our protocol was drafted using the Preferred Reporting Items for Systematic Reviews and Meta-analyses for scoping reviews. To assess the reliability of the CPGs, we used all the domains included in the Appraisal of Guidelines Research and Evaluation II. Results: We selected three CPGs published or updated between 2015 and 2020. All the guidelines showed good or adequate methodological rigor but presented pitfalls in stakeholder involvement and applicability domains. Recommendations were coherent across CPGs on steroid treatment, except for minor differences in dosing regimens. However, the recommendations were different for new drugs. Discussion: There is a need for current and reliable CPGs that develop broad topics on the management of DMD and consider the challenges of developing recommendations for RDs. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Copyright \u00a9 2024 Malaga, Rodriguez-Calienes, Chavez-Ecos, Huerta-Rosario, Alvarado-Gamarra, Cabanillas-Lazo, Moran-Ballon, Vel\u00e1squez-Rimachi, Martinez-Esteban and Alva-Diaz.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=38249725&authtype=shib&custid=ns346513","isPdfLink":true,"isSAML":false,"additionalInfo":{"Authored_By":"Malaga M, Rodriguez-Calienes A, Chavez-Ecos FA, Huerta-Rosario A, Alvarado-Gamarra G, Cabanillas-Lazo M, Moran-Ballon P, Vel\u00e1squez-Rimachi V, Martinez-Esteban P, Alva-Diaz C","Journal_Info":"Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE","Publication_Type":"Journal Article; Scoping Review","Published_Date":"2024-01-05","Source":"Frontiers in neurology [Front Neurol] 2024 Jan 05; Vol. 14, pp. 1260610. Date of Electronic Publication: 2024 Jan 05 (Print Publication: 2023).","Languages":"English","Title_Abbreviations":"Frontiers in neurology","Volume":"14"},"header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"38249725","RelevancyScore":"934","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"934.100952148438"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=38249725&authtype=shib&custid=ns346513&group=main&profile=eds","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=38249725&authtype=shib&custid=ns346513&group=main&profile=eds"}